Whenever a technology enters healthcare, two symmetrical and equally wrong reactions appear: the enthusiasm that treats it as a miracle and the scepticism that dismisses it as a fad. Virtual reality for clinical use is no exception. The useful — and honest — reading sits in between, and it requires looking at the evidence carefully.
What is more established
The most studied application of virtual reality in healthcare is distraction for the management of pain and anxiety. The mechanism is plausible and well described: attention is a finite resource, and an immersive environment occupies it, leaving less capacity to process pain or anxiety.
There is a growing body of research pointing to benefits of this distraction effect across several clinical contexts — short procedures, anxiety tied to waiting, discomfort. It is one of the areas where the evidence is most consistent.
That immersive distraction helps reduce perceived pain and anxiety is among the points best supported by current research.
What is still consolidating
Not all applications are at the same level. Many are at earlier stages, with smaller or less conclusive studies. Here caution is needed:
- Strength varies widely between applications — what holds for acute pain does not automatically transfer to other uses.
- Many studies have small samples or designs that limit strong conclusions.
- In several areas, larger-scale and long-term studies are still lacking.
Acknowledging this does not weaken the technology — it makes the discourse credible.
How to read the evidence without falling into extremes
Some practical principles for interpreting claims about VR in healthcare:
- Be wary of absolutes. "Cure" or "eliminates pain" are warning signs, not science.
- Distinguish applications. A claim only holds for the context in which it was studied.
- Value caution. Those who acknowledge the limits of the evidence are usually more reliable than those who promise everything.
- Defer the decision to the clinic. Interpreting results and deciding on use rest with healthcare professionals.
Important note: virtual reality for clinical use is a complementary, non-pharmacological approach, presented on the basis of the available evidence and used under the supervision of healthcare professionals. It does not replace proven treatments, clinical assessment, or medical prescription. This article is informational and does not constitute clinical advice.
The role of RVer
RVer is an immersive virtual reality therapy system designed for healthcare environments and registered as a Class I Medical Device (base product) with Infarmed, bearing the CE mark under MDR 2017/745. The registration and the CE marking attest to regulatory compliance and safety for its intended use — and the stance is deliberately cautious: to offer a validated, complementary tool, without promising what the evidence does not yet support.
The honest approach to science is not the one that promises the most — it is the one that clearly distinguishes what is already known from what is still being studied.